Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jonathan Brammer

Clinical trials sponsored by Jonathan Brammer, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug may keep T-Cell lymphoma at bay after transplant Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet finished but already full! 1

New pill shows promise for Hard-to-Treat blood cancer

Disease control Ongoing

This early-phase trial is testing an oral chemotherapy drug called azacitidine (CC-486) in 11 adults with a rare type of leukemia (T-LGLL) that has come back or not responded to prior treatment. The study aims to find the best dose and see how well the drug works at shrinking or …

Phase 1/2 • Sponsor: Jonathan Brammer • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC